Sparsity of dendritic cells and cytotoxic T cells in tumor microenvironment may lead to recurrence in basal cell carcinoma

被引:12
作者
Beksac, Burcu [1 ]
Ilter, Nilsel [1 ]
Erdem, Ozlem [2 ]
Cakmak, Pinar [2 ]
Cenetoglu, Seyhan [3 ]
Yapar, Dilek [4 ]
机构
[1] Gazi Univ, Fac Med, Dept Dermatol, Ankara, Turkey
[2] Gazi Univ, Fac Med, Dept Pathol, Ankara, Turkey
[3] Gazi Univ, Fac Med, Dept Plast Reconstruct & Aesthet Surg, Ankara, Turkey
[4] Gazi Univ, Fac Med, Dept Publ Hlth, Ankara, Turkey
关键词
LANGERHANS CELLS; SKIN CANCERS; NUMBER;
D O I
10.1111/ijd.15065
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Antitumor immune response affects tumor growth. The effect of antitumor immune response on recurrence has been poorly studied in basal cell carcinoma (BCC). Objectives To investigate the effects of the peritumoral immune infiltrate on BCC recurrence. Methods A total of 30 BCC patients without recurrence and 29 BCC patients with recurrence were included in this retrospective study. Non-recurrent tumor samples as well as primary and recurrent tumor samples from the recurrent group were stained immunohistochemically with anti-CD4, CD8, CD25, FOXP3, CD68, CD163, and CD1a antibodies. Immune infiltrates were semiquantitatively evaluated. Results BCC tumor microenvironment was rich in CD4+ cells. CD163 expression was higher than CD68. In primary tumors of the recurrent group, CD8 expression was significantly lower than CD4 expression. CD1a expression was lower in primary tumors of the recurrent group than in nonrecurrent tumors. Conclusions Our results suggest the existence of an immunosuppressive microenvironment in BCC. Lower CD8+ T-cell numbers and sparsity of dendritic cells in primary tumors of recurrent patients suggest further immunosuppression in the tumor microenvironment and an increase in recurrence risk. This is the first study that evaluates and compares tumor immune microenvironments of primary and recurrent BCC lesions with several markers and investigates the role of antitumor immunity on BCC recurrence.
引用
收藏
页码:1258 / 1263
页数:6
相关论文
共 26 条
[1]   Composition and Clinical Impact of the Immunologic Tumor Microenvironment in Oral Squamous Cell Carcinoma [J].
Boxberg, Melanie ;
Leising, Lena ;
Steiger, Katja ;
Jesinghaus, Moritz ;
Alkhamas, Aezlat ;
Mielke, Marion ;
Pfarr, Nicole ;
Goetz, Carolin ;
Wolff, Klaus Dietrich ;
Weichert, Wilko ;
Kolk, Andreas .
JOURNAL OF IMMUNOLOGY, 2019, 202 (01) :278-291
[2]   In vivo characterization of the inflammatory infiltrate and apoptotic status in imiquimod-treated basal cell carcinoma [J].
De Giorgi, Vincenzo ;
Salvini, Camilla ;
Chiarugi, Alessandra ;
Paglierani, Milena ;
Maio, Vincenza ;
Nicoletti, Paola ;
Santucci, Marco ;
Carli, Paolo ;
Massi, Daniela .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2009, 48 (03) :312-321
[3]   The epidemiology of skin cancer [J].
Diepgen, TL ;
Mahler, V .
BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 :1-6
[4]   Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment [J].
Fu, Chunmei ;
Jiang, Aimin .
FRONTIERS IN IMMUNOLOGY, 2018, 9
[5]   Human basal cell carcinoma is associated with Foxp3+ T cells in a Th2 dominant microenvironment [J].
Kaporis, Helen G. ;
Guttman-Yassky, Emma ;
Lowes, Michelle A. ;
Haider, Asifa S. ;
Fuentes-Duculan, Judilyn ;
Darabi, Kamruz ;
Whynot-Ertelt, Julia ;
Khatcherian, Artemis ;
Cardinale, Irma ;
Novitskaya, Inna ;
Krueger, James G. ;
Carucci, John A. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (10) :2391-2398
[6]   Basal cell carcinoma progression correlates with host immune response and stromal alterations: A histologic analysis [J].
Kaur, Prahbjot ;
Mulvaney, Michael ;
Carlson, J. Andrew .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2006, 28 (04) :293-307
[7]   Aggressive Behavior of Nonmelanotic Skin Cancers in Solid Organ Transplant Recipients [J].
Lott, David G. ;
Manz, Ryan ;
Koch, Carl ;
Lorenz, Robert R. .
TRANSPLANTATION, 2010, 90 (06) :683-687
[8]  
Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
[9]  
Mroue Rana, 2013, Methods Mol Biol, V945, P221, DOI 10.1007/978-1-62703-125-7_14
[10]  
Nestle FO, 1997, AM J PATHOL, V150, P641